Iovance Biotherapeutics, Inc. (0JDK)
Market Closed
17 Jul, 15:30
$
4. 90
+0.09
+1.9127%
$
- Market Cap
- P/E Ratio
- Div Yield
269,771 Volume
-1.87 Eps
$ 4.81
Previous Close Want to track 0JDK and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Iovance Biotherapeutics, Inc. (0JDK) Statistics
Valuation metrics
Market Cap -
Enterprise value 1.64B
Trailing P/E (ttm) -5.43
Forward P/E -
PEG ratio -0.18
Price/Sales (ttm) 6.26
Price/Book (mrq) 2.9
Enterprise Value/Revenue 5.74
Enterprise Value/EBITDA -5.1
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 228.42K
Average volume (90 days) 168.93K
Price summary
52-Week low 1.76
52-Week high 5.69
Beta -
50-Day moving average 4.17
200-Day moving average 3.56
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:100
Last split Date 26 Sep 2013
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -1.24%
Operating margin -1.27%
Operational effectiveness
Return on assets -0.38%
Return on equity -0.5%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.68
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.85
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.75
Total debt (mrq) -
Total Debt/Equity (mrq) 0.07
Current ratio (mrq) 3.6%
Book value per share (mrq) 1.72
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
